The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 7
- 7 new
- Median first-year cost
- $2,095,914
- $14,593,413 in all
- Institutions
- 7
- 7 contact PIs
- Patents
- 2
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- HARVARD MEDICAL SCHOOL1
- J. DAVID GLADSTONE INSTITUTES1
- MASSACHUSETTS GENERAL HOSPITAL1
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY1
- STANFORD UNIVERSITY1
and 2 other institutions
Most frequent study sections
- Special Emphasis Panel (ZAG1 ZIJ-5 (M1))7
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2014 | Studying Alzheimer's Disease Using Human iPS Cells1RF1AG048030-01 | Huang, Yadong | J. DAVID GLADSTONE INSTITUTES, CA | First-year cost $2,387,500 | Study section ZAG1 |
| FY2014 | Alzheimer's Disease Risk Genes in Human Microglia and Neurons Derived from iPSCs1RF1AG048029-01 | Tsai, Li-Huei | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | First-year cost $2,126,485 | Study section ZAG1 |
| FY2014 | A novel human 3D neural cell culture system for the characterization of AD genes1RF1AG048080-01 | Kim, Doo YeonTanzi, Rudolph Emile | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $2,119,500 | Study section ZAG1 |
| FY2014 | Genome Engineering an IPSC Model of Alzheimer's Disease1RF1AG048056-01 | Church, George MYankner, Bruce A | HARVARD MEDICAL SCHOOL, MA | First-year cost $2,095,914 | Study section ZAG1 |
| FY2014 | Probing Alzheimer synaptopathy in neurons derived from engineered human iPS cells1RF1AG048131-01 | Sudhof, Thomas C.Wernig, Marius | STANFORD UNIVERSITY, CA | First-year cost $2,006,250 | Study section ZAG1 |
| FY2014 | Elucidating AD genotype-phenotype relationships using genetics of human IPS cells1RF1AG048083-01 | Goldstein, Lawrence S. | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | First-year cost $1,936,014 | Study section ZAG1 |
| FY2014 | The role of TREM2 in human microglial function and Alzheimer disease pathogenesis1RF1AG048099-01 | Blurton-Jones, Mathew Mark | UNIVERSITY OF CALIFORNIA-IRVINE, CA | First-year cost $1,921,750 | Study section ZAG1 |
Patents from its funded projects
2 patents name 1 of the 7 funded projects.
- US 12,195,756 (opens the patent at USPTO, a PDF, in a new tab)Transcription factor-mediated differentiation of oligodendrocyte progenitors, and synthetic biology methods to immuno-protect stem cell-derived cellsGranted January 14, 2025 to President and Fellows of Harvard CollegeRF1AG048056 · HARVARD MEDICAL SCHOOL, MA
- US 12,031,153 (opens the patent at USPTO, a PDF, in a new tab)METHODS AND COMPOSITIONS FOR THE PRODUCTION OF OLIGODENDROCYTE PROGENITOR CELLSGranted July 9, 2024 to President and Fellows of Harvard CollegeRF1AG048056 · HARVARD MEDICAL SCHOOL, MA
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.